Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Research crawled date : 2022 - 04 - 11 save search
Kintara Therapeutics Presents Data at the 2022 American Association for Cancer Research Annual Meeting
Published: 2022-04-11 (Crawled : 19:00) - prnewswire.com
KTRA | $0.1374 3.54% 3.42% 5.8M
|
Distribution Services
|
| O: -17.85%
H: 6.36%
C: -15.65%
research therapeutics cancer
Josh Blount Elevated to Regional Director for the Ductile Iron Pipe Research Association
Published: 2022-04-11 (Crawled : 19:00) - prnewswire.com
AWK | $121.36 1.24% 0.0% 1.3M
|
Utilities
|
| O: -0.13%
H: 1.25%
C: -0.27%
research
Context Therapeutics® Announces Encouraging Preclinical Data from Two Programs to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-04-11 (Crawled : 16:00) - biospace.com/
CNTX | $1.38 -2.13% -2.17% 37K
|
Health Technology
|
| O: -2.6%
H: 0.65%
C: -20.17%
therapeutics research preclinical cancer pre-clinical
Beyond Cancer™ Announces New Preclinical Data Presented at American Association for Cancer Research (AACR) Showing Ultra-High Concentration Nitric Oxide Therapy Anti-Tumor Effect
Published: 2022-04-11 (Crawled : 16:00) - biospace.com/
XAIR | $1.31 8.26% 7.63% 410K
|
Technology Services
|
| O: -2.46%
H: 0.01%
C: -5.63%
research preclinical therapy cancer pre-clinical
Robotic Vacuum Cleaner Market - 2021-2025 | Inclusion Of Air Filters In Robotic Vacuum Cleaners to Boost Market Growth | 17,000+ Technavio Research Reports
Published: 2022-04-11 (Crawled : 16:00) - prnewswire.com
PCRFF | News | $8.88 -1.12% 990
|
n/a
|
| O: -2.13%
H: 3.07%
C: 2.23%
PCRFY | News | $9.52 -0.11% 420K
|
n/a
|
| O: -1.42%
H: 1.11%
C: 0.22%
RYLPF | $20.52 3.85% 110K
|
Health Technology
|
| O: -0.61%
H: 0.0%
C: 0.0%
air research growth market
Global Anti-counterfeit Packaging Market Size Projected to Reach Around USD 319.38 Billion By 2030, with 12.6% CAGR: Polaris Market Research
Published: 2022-04-11 (Crawled : 15:00) - prnewswire.com
AVY | $212.42 0.52% 0.0% 780K
|
Process Industries
|
| O: 0.11%
H: 1.34%
C: -0.24%
MMM | $92.02 -1.05% 0.0% 3.8M
|
Producer Manufacturing
|
| O: 0.43%
H: 1.18%
C: -0.22%
research market
aTyr Pharma Presents Preclinical Research Characterizing Effects of ATYR2810 in Highly Aggressive Tumor Subtypes at the 2022 AACR Annual Meeting
Published: 2022-04-11 (Crawled : 14:00) - biospace.com/
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: -1.38%
H: 1.0%
C: -2.2%
atyr2810 pharma research preclinical pre-clinical
Ice Cream Market to Reach $122.05 Billion, Globally, by 2031 at 5.0% CAGR: Allied Market Research
Published: 2022-04-11 (Crawled : 14:00) - prnewswire.com
GIS 4 | $71.61 1.12% 0.0% 4.4M
|
Consumer Non-Durables
|
| O: 0.7%
H: 0.42%
C: -0.21%
research market
LED Market to Garner $192.7 Bn, Globally, by 2030 at 8.2% CAGR: Allied Market Research
Published: 2022-04-11 (Crawled : 14:00) - prnewswire.com
PHG | News | $20.97 -0.19% 0.0% 650K
|
Health Technology
|
| O: -0.93%
H: 0.64%
C: -2.12%
GE | News | $159.19 -2.11% 0.0% 10M
|
Electronic Technology
|
| O: -0.22%
H: 2.28%
C: 0.15%
research market
Alzamend Neuro Contracts with Altasciences and iResearch Atlanta to Manage and Conduct Its Phase IIA Study in Patients with Alzheimer’s
Published: 2022-04-11 (Crawled : 13:20) - biospace.com/
ALZN | $0.729 0.47% 0.47% 20K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 0.0%
C: -6.25%
alzheimer’s alzheimer's
NeuroSense Therapeutics Commences Enrollment and Dosing in its Pharmacokinetic Study of PrimeC for ALS
Published: 2022-04-11 (Crawled : 13:20) - biospace.com/
NRSN | News | $1.33 -2.21% -2.26% 130K
|
|
| O: -2.12%
H: 0.72%
C: -13.72%
primec als therapeutics enroll
Lumos Pharma Reaches 50% Randomization Milestone in Phase 2 OraGrowtH210 Trial Evaluating Oral LUM-201 in PGHD
Published: 2022-04-11 (Crawled : 13:20) - biospace.com/
LUMO | $2.795 -0.18% -0.18% 46K
|
Health Technology
|
| O: -0.33%
H: 4.92%
C: 4.92%
lum-201 pharma trial milestone phase 2
Nuvectis Pharma Recaps Oral Presentation Highlights for NXP800 at the 2022 American Association for Cancer Research (AACR) Conference
Published: 2022-04-11 (Crawled : 13:00) - biospace.com/
NVCT | $6.715 1.9% 1.86% 51K
|
|
| O: -2.01%
H: 5.4%
C: 5.18%
nxp800 pharma research conference presentation cancer
Surface Disinfectant Market to Reach $9.52 Billion by 2029 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®
Published: 2022-04-11 (Crawled : 13:00) - prnewswire.com
RBGPF | News | $52.06 6.46% 4.8K
|
Consumer Non-Durables
|
| O: 0.86%
H: 0.0%
C: -2.97%
RBGLY | News | $10.59 -2.05% 850K
|
Manufacturing
|
| O: -2.75%
H: 1.84%
C: 1.32%
STE | $202.8 -1.55% 0.0% 490K
|
Health Technology
|
| O: -0.4%
H: 0.39%
C: -0.36%
ECL | News | $220.78 0.51% 0.0% 710K
|
Process Industries
|
| O: -0.72%
H: 1.01%
C: -0.6%
MMM | $92.02 -1.05% 0.0% 3.8M
|
Producer Manufacturing
|
| O: 0.43%
H: 1.18%
C: -0.22%
covid-19 research report disinfectant market
Spectrum Pharmaceuticals Announces FDA Acceptance of BLA Resubmission for Eflapegrastim
Published: 2022-04-11 (Crawled : 12:20) - biospace.com/
SPPI | $1.03 -0.97% 0
|
Health Technology
|
| O: 5.26%
H: 1.67%
C: -7.5%
fda resubmission eflapegrastim
Recursion is Granted Fast Track Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis
Published: 2022-04-11 (Crawled : 12:20) - biospace.com/
RXRX | $7.94 3.12% 3.02% 7.1M
|
Professional, Scientific, and T...
|
| O: -2.26%
H: 10.31%
C: 5.85%
rec-4881 treatment granted potential fast track designation designation
Health Canada Approves GARDASIL (Human Papillomavirus 9-valent Vaccine, Recombinant) for the Prevention of Oropharyngeal and Other Head and Neck Cancers
Published: 2022-04-11 (Crawled : 12:20) - biospace.com/
MRK | $127.0 0.1% -1.21% 7.1M
|
Health Technology
|
| O: 0.73%
H: 1.31%
C: -1.91%
canada health
RedHill Biopharma Ltd Announces Potent Omicron Inhibition with RedHill's Opaganib
Published: 2022-04-11 (Crawled : 12:20) - biospace.com/
RDHL | $0.415 -2.99% -3.08% 190K
|
Health Technology
|
| O: -3.42%
H: 17.26%
C: -7.96%
biopharma opaganib
Moderna Announces First Participants Dosed in Phase 1/2 Study with mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccine Candidates
Published: 2022-04-11 (Crawled : 12:20) - biospace.com/
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: -3.01%
H: 4.71%
C: 2.56%
rna-1020 vaccine influenza phase 1
Zentek Announces Start of Phase Two Testing of ZenGUARD(TM) - Coated Filters Under ISC Testing Stream Contract
Published: 2022-04-11 (Crawled : 12:20) - biospace.com/
ZTEK | $1.14 1.33% 13K
|
Professional, Scientific, and T...
|
| O: -0.35%
H: 2.48%
C: -6.03%
contract test
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.